1. Japan Stocks

  2. •

    Healthcare

  3. •

    Medical - Healthcare Information Services
M3, Inc.

M3, Inc.

MTHRY
M3, Inc.US flagOther OTC
4.77
USD
+0.01
- -
6.37BMarket Cap
M3, Inc.
MTHRY
(Other OTC)

Recent

price

4.77

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
9.4
11.65
15.06
20.48
28.84
39.7
49.96
60.35
72.94
87.26
96.52
124.66
153.34
170
175.93
209.78
90.63
Revenue per Share
1.54
2.77
3.55
4.41
6.6
7.55
9.66
12.36
14
15.11
15.94
27.87
47.03
36.11
33.34
29.81
16.1
Basic EPS, GAAP
2.65
2.37
3.98
4.38
6.55
6.64
8.8
12.19
10.86
12.66
17.65
32.89
36.01
38.12
37.36
31.48
21.57
Free Cash Flow per Basic Share
0.68
0.75
1.03
1.04
1.5
1.62
2
2.25
2.5
2.59
3.34
4.25
6
8
9.5
10.5
- -
Dividend per Share
7.41
9.4
11.93
15.63
20.77
26.4
34.07
44.17
56.88
70.81
98.88
122.44
163.56
191.79
215.7
235.04
217.88
Book Value per Share
7.33
8.92
9.37
13.37
17.26
20.76
24.94
19.93
26.56
35.05
73.87
96.8
133.37
145.43
161.74
151.89
160.41
Tangible Book Value per Share
1,256
1,257
1,264
1,270
1,275
1,293
1,294
1,295
1,295
1,296
1,357
1,357
1,358
1,358
1,358
1,358
1,358
Basic Weighted Avg Shares
11,812
14,647
19,041
26,008
36,759
51,346
64,660
78,143
94,471
113,059
130,973
169,198
208,159
230,818
238,883
284,900
123,088
Sales/Revenue/Turnover
52.79
54.81
40.17
35.74
34.14
31.21
30.85
31.76
29.06
27.15
26.3
34.28
31.81
30.55
26.38
21.16
23.36
Operating Margin (%)
285
375
557
613
375
671
867
939
1,161
1,391
4,493
5,736
6,274
7,434
8,878
12,205
4,691
Depreciation Expense
1,939
3,487
4,493
5,599
8,415
9,759
12,508
16,004
18,127
19,577
21,635
37,822
63,845
49,028
45,271
40,484
21,865
Net Income, GAAP
52.41
41.09
39.9
38.42
36.25
35.53
32.37
32.14
30.02
31.01
30.21
29.29
31.27
30.05
29.48
31.56
25.72
Effective Tax Rate (%)
16.41
23.81
23.6
21.53
22.89
19.01
19.34
20.48
19.19
17.32
16.52
22.35
30.67
21.24
18.95
14.21
17.76
Profit Margin (%)
7,963
9,649
9,724
11,767
17,309
20,057
23,875
21,267
29,041
35,987
83,401
113,801
141,658
143,891
173,570
161,311
174,235
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
94
16,483
21,342
21,705
LT Debt
11,258
13,708
17,481
23,426
37,461
46,510
56,562
69,510
85,168
102,276
171,601
207,260
263,953
309,518
366,701
412,799
364,450
Total Equity
24.75
33.66
26.25
25.25
24.25
22.95
24.46
24.97
23.33
21.35
16.68
20.49
18.38
16.59
12.46
9.83
5.69
Return on Invested Capital (%)
21.34
31.37
31.33
29.35
33.07
28.99
28.63
28.73
25.1
20.76
16.3
22.04
30.67
18.61
14.24
10.54
6.68
Return on Capital (%)
22.14
33
33.4
32.05
36.32
32.19
31.97
31.6
27.7
23.67
19.15
25.18
32.89
20.32
16.36
13.23
7.71
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
ST Debt
2,031
- -
2,727
LT Borrowings
16,483
- -
21,705
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
679
- -
679
Market Capitalization
1,474,496
1,042,840
964,432

Working Capital

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
Total Current Assets
240,739
- -
238,389
Cash, Cash Equivalents & STI
179,828
- -
179,751
Accounts Receivable, Net
51,928
- -
49,511
Inventories
- -
- -
- -
Total Current Liabilities
67,169
- -
64,154
Payables & Accruals
- -
- -
- -
ST Debt
2,031
- -
2,727
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
25.13%
19.29%
12.57%
Free Cash Flow
20.7%
16.82%
-15.72%
Net Income, GAAP
19.01%
20.44%
-10.57%
Sales/Revenue/Turnover
18.91%
17.17%
19.26%
Total Cash Common Dividend
21.68%
26.22%
10.55%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
57,396
58,399
63,394
59,694
238,883
2025
- -
- -
- -
- -
284,900
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
9.14
8.1
9.73
- -
33.34
2025
- -
- -
- -
- -
29.81
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
8.84
0.65
- -
- -
9.5
2025
- -
- -
- -
- -
10.5
2026
- -
- -
- -
- -
- -
Similar Companies
Castlight Health, Inc. (CSLT)
Mental Health Technologies Co.,Ltd. (9218.T)
CE Holdings Co., Ltd. (4320.T)
SomaLogic, Inc. (SLGCW)
CloudMD Software & Services Inc. (DOC.V)
FRISQ Holding AB (publ) (FRISQ.ST)
Business
M3, Inc. (MTHRY) provides medical-related services primarily to physicians and other healthcare professionals through Internet-based platforms and real-world operations. The company operates six reportable segments: Medical Platform, which offers online marketing services including m3.com for healthcare professionals, MR-kun for medical information delivery, QOL-kun for lifestyle support, and AskDoctors for public health queries; Evidence Solutions, which supports clinical trials and research; Career Solutions, which delivers human resources services such as recruitment and job postings via m3.com CAREER for doctors and pharmacists; Site Solutions, which provides operational support including electronic medical records, medical equipment, and home-visit nursing for institutions; Patient Solutions; and Overseas, which delivers similar services in the United States via MDLinx, the United Kingdom via Doctors.net.uk, China, South Korea, India, France, Germany, and Spain. Founded in 2000 and headquartered in Tokyo, Japan, M3 serves pharmaceutical companies, medical institutions, and patients across Japan and internationally, with a focus on digital healthcare marketing, recruitment, research, and clinical support. Recent developments include the August 2025 acquisition by VIDAL Group of GPR, a French prescription support tool for renal failure; the March 2025 acquisition and consolidation of EWEL, Inc.; the February 2025 acquisition of Limbic Digital Media, an Australian medical news provider; and ongoing share repurchases under its articles of incorporation as announced in December 2025, alongside FY2025 Q2 financial results release in November 2025.

Company News

APIChat